EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Tackling Drug-Resistant Tuberculosis: New Challenges from the Old Pathogen Mycobacterium tuberculosis

Giuseppe Mancuso, Angelina Midiri, Silvia De Gaetano, Elena Ponzo iD, Carmelo Biondo

Microorganisms · 10.09.2023 · 11 (9) · 2277

DOI: 10.3390/microorganisms11092277 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Microorganisms, online erschienen am 10.09.2023. Verfasst von Giuseppe Mancuso und 4 weiteren Autor:innen. Beteiligte Einrichtung: Mycobacteriology Unit, Department of Human Pathology, University of Messina, 98125 Messina, Italy. Die Arbeit wurde bisher 76-mal zitiert (Crossref) und nennt 118 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Antibiotics have played a crucial role in the reduction in the incidence of TB globally as evidenced by the fact that before the mid-20th century, the mortality rate within five years of the onset of the disease was 50%. The use of antibiotics has eliminated TB as a devastating disease, but the challenge of resistance to anti-TB drugs, which had already been described at the time of the introduction of streptomycin, has become a major global issue in disease management. Mismanagement of multidrug-resistant tuberculosis (MDR-TB) cases, resulting from intermittent drug use, prescription errors, and non-compliance of patients, has been identified as a critical risk factor for the development of extensively drug-resistant tuberculosis (XDR-TB). Antimicrobial resistance (AMR) in TB is a multi-factorial, complex problem of microbes evolving to escape antibiotics, the gradual decline in antibiotic development, and different economic and social conditions. In this review, we summarize recent advances in our understanding of how Mycobacterium tuberculosis evolves drug resistance. We also highlight the importance of developing shorter regimens that rapidly reach bacteria in diverse host environments, eradicating all mycobacterial populations and preventing the evolution of drug resistance. Lastly, we also emphasize that the current burden of this ancient disease is driven by a combination of complex interactions between mycobacterial and host factors, and that only a holistic approach that effectively addresses all the critical issues associated with drug resistance will limit the further spread of drug-resistant strains throughout the community.

Schlagwörter

Stichwörter der Autor:innen

M.tb pathogenesisMDR-TBXDR-TBdrug tolerancenew approaches

Autor:innen und Institutionen

  • Mycobacteriology Unit, Department of Human Pathology, University of Messina, 98125 Messina, Italy.

ORCID-Profile: Elena Ponzo

Zitieren

APA

Mancuso, G., Midiri, A., De Gaetano, S., Ponzo, E., & Biondo, C. (2023). Tackling Drug-Resistant Tuberculosis: New Challenges from the Old Pathogen Mycobacterium tuberculosis. Microorganisms, 11(9), 2277. https://doi.org/10.3390/microorganisms11092277

Vancouver

Mancuso G, Midiri A, De Gaetano S, Ponzo E, Biondo C. Tackling Drug-Resistant Tuberculosis: New Challenges from the Old Pathogen Mycobacterium tuberculosis. Microorganisms. 2023;11(9):2277. doi:10.3390/microorganisms11092277

BibTeX
@article{Mancuso2023,
  author = {Mancuso, Giuseppe and Midiri, Angelina and De Gaetano, Silvia and Ponzo, Elena and Biondo, Carmelo},
  title = {Tackling Drug-Resistant Tuberculosis: New Challenges from the Old Pathogen Mycobacterium tuberculosis},
  journal = {Microorganisms},
  year = {2023},
  volume = {11},
  number = {9},
  pages = {2277},
  doi = {10.3390/microorganisms11092277}
}
Kostenlos starten →